Wolverine Asset Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-101,713
Closed -$5.7K 2169
2023
Q3
$5.7K Hold
101,713
﹤0.01% 1545
2023
Q2
$15K Hold
101,713
﹤0.01% 1334
2023
Q1
$9.66K Hold
101,713
﹤0.01% 1456
2022
Q4
$10.2K Hold
101,713
﹤0.01% 1628
2022
Q3
$8K Hold
101,713
﹤0.01% 2072
2022
Q2
$14K Sell
101,713
-1,130
-1% -$211 ﹤0.01% 1909
2022
Q1
$23K Buy
+102,843
New +$26.7K ﹤0.01% 1737

Wolverine Asset Management's BIOSW Position: Q4 2023 in Review

Wolverine Asset Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 101,713 shares — an estimated $5.7K sold.

Wolverine Asset Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $23K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Wolverine Asset Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 101,713 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $5.7K.
  • Wolverine Asset Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • Wolverine Asset Management's BioPlus Acquisition Corp. Warrants position peaked at $23K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.